Novartis
NVS
NVS
1,141 hedge funds and large institutions have $16.9B invested in Novartis in 2022 Q2 according to their latest regulatory filings, with 89 funds opening new positions, 348 increasing their positions, 447 reducing their positions, and 75 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.25% less ownership
Funds ownership: 8.55% → 8.31% (-0.25%)
7% less capital invested
Capital invested by funds: $18.2B → $16.9B (-$1.33B)
22% less repeat investments, than reductions
Existing positions increased: 348 | Existing positions reduced: 447
Holders
1,141
Holding in Top 10
8
Calls
$322M
Puts
$215M
Top Buyers
| 1 | +$265M | |
| 2 | +$142M | |
| 3 | +$40M | |
| 4 |
JP Morgan Chase
New York
|
+$37.6M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$36.5M |
Top Sellers
| 1 | -$447M | |
| 2 | -$154M | |
| 3 | -$93.6M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$64.8M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$48.2M |